- Corporate Officers - C
- Cpmg Inc
Insider Trading History of Cpmg Inc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cpmg Inc since 2008.
This trader's CIK number is 1372218.
At the time of last reporting, Cpmg Inc was the Officer of Apollo Endosurgery, Inc.. (stock ticker symbol APEN).
Also see all insider trading activities at Apollo Endosurgery, Inc..
Note that in the past
CPMG Inc also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Apollo Endosurgery, Inc. (APEN) by Cpmg Inc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | APEN | 683,871 | $5,300,000 | 0 | $0 | 0 | $0 |
| 2020 | APEN | 1,780,000 | $2,225,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Genitope Corp (GTOP) by Cpmg Inc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | GTOP | 0 | $0 | 8,125,370 | $0 | 0 | $0 |
Yearly summary of insider trading at Reata Pharmaceuticals Inc (RETA) by Cpmg Inc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | RETA | 40,218 | $7,359,894 | 0 | $0 | 0 | $0 |
| 2018 | RETA | 110,826 | $6,579,351 | 0 | $0 | 0 | $0 |
| 2017 | RETA | 253,592 | $6,296,921 | 0 | $0 | 0 | $0 |
| 2016 | RETA | 1,003,673 | $17,740,964 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Cpmg Inc:
1. Apollo Endosurgery, Inc. (APEN)
2. Genitope Corp (GTOP)
3. Reata Pharmaceuticals Inc (RETA)
Table 1. Insider trading of Apollo Endosurgery, Inc. (APEN) by Cpmg Inc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-10-15 | APEN | Buy | 683,871 | 7.75 | 5,300,000 |
| 2020-07-17 | APEN | Buy | 1,780,000 | 1.25 | 2,225,000 |
Table 2. Insider trading of Genitope Corp (GTOP) by Cpmg Inc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-12-10 | GTOP | Sale | 8,125,370 | .00 | 0 |
Table 3. Insider trading of Reata Pharmaceuticals Inc (RETA) by Cpmg Inc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-11-18 | RETA | Buy | 40,218 | 183.00 | 7,359,894 |
| 2018-12-10 | RETA | Buy | 56,599 | 58.70 | 3,322,078 |
| 2018-12-11 | RETA | Buy | 52,809 | 60.07 | 3,172,342 |
| 2018-12-12 | RETA | Buy | 1,418 | 59.90 | 84,931 |
| 2017-12-29 | RETA | Buy | 17,000 | 28.47 | 484,024 |
| 2017-12-28 | RETA | Buy | 200 | 26.10 | 5,220 |
| 2017-12-27 | RETA | Buy | 15,000 | 25.83 | 387,450 |
| 2017-12-26 | RETA | Buy | 12,000 | 26.06 | 312,732 |
| 2017-12-13 | RETA | Buy | 121,725 | 24.43 | 2,973,741 |
| 2017-12-14 | RETA | Buy | 78,275 | 24.65 | 1,929,713 |
| 2016-12-30 | RETA | Buy | 9,392 | 21.73 | 204,041 |
| 2016-12-16 | RETA | Buy | 164,753 | 22.99 | 3,787,836 |
| 2016-12-14 | RETA | Buy | 6,189 | 21.36 | 132,227 |
| 2016-12-15 | RETA | Buy | 2,700 | 22.05 | 59,535 |
| 2016-08-16 | RETA | Buy | 58,600 | 16.21 | 949,964 |
| 2016-08-17 | RETA | Buy | 144,058 | 17.26 | 2,486,873 |
| 2016-08-18 | RETA | Buy | 105,562 | 17.32 | 1,828,650 |
| 2016-06-29 | RETA | Buy | 63,700 | 19.83 | 1,263,043 |
| 2016-06-30 | RETA | Buy | 100,000 | 19.75 | 1,975,100 |
| 2016-06-28 | RETA | Buy | 900 | 19.74 | 17,763 |
| 2016-06-27 | RETA | Buy | 21,968 | 19.18 | 421,236 |
| 2016-06-24 | RETA | Buy | 51,435 | 18.92 | 973,150 |
| 2016-06-06 | RETA | Buy | 20,000 | 17.56 | 351,200 |
| 2016-06-07 | RETA | Buy | 4,220 | 17.62 | 74,360 |
| 2016-06-01 | RETA | Buy | 8,035 | 13.42 | 107,829 |
| 2016-06-01 | RETA | Buy | 251,553 | 13.17 | 3,312,198 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Cpmg Inc
(Officer of Apollo Endosurgery, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.